January 16 . 2006

Dr. Frank Davidoff

What should the determining factors be when approving a drug for distribution? Should morality and political influence ever be used as a basis? Joining us is Dr. Frank Davidoff, Executive Editor Institute for Healthcare Improvement who resigned from the FDA’s Nonprescription Drugs Advisory Committee to tell us what prompted him to do so.